Companies / Passage BIO, Inc.

Passage BIO, Inc.

Nasdaq: PASGCIK 1787297PHILADELPHIA, PA

Financials

Revenue
Net income$-45.52M
Total debt
Cash$24.16M
Diluted EPS$-14.35
Shares outstanding3.2M

Ownership

3.2M shares outstanding · as of Aug 5, 2026
0.37%Insiders
Ownership
Insiders0.37%11,926
Institutions50.06%1,610,931
Public float49.57%1,594,953

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Chou WilliamCEOPRESIDENT AND CEO · Director
0.20%6,524
0.17%5,402
Gowen MaxineDirector

Institutional holders 32

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 8, 2026Chou William
CEO
SellCommon Stock$75.2K-4K
-38.45%
6,524
0.20% of shares
low
Jan 8, 2026Borthwick Kathleen
Executive
SellCommon Stock$38.0K-2K
-27.63%
5,402
0.17% of shares
low
May 19, 2026Kassberg Thomas Richard
Director
GrantDirector Stock Option (right to buy)+11K
10,539
0.33% of shares
low
May 19, 2026Gowen Maxine
Director
GrantDirector Stock Option (right to buy)+11K
10,539
0.33% of shares
low
Mar 16, 2026Borthwick Kathleen
Executive
GrantEmployee Stock Option (right to buy)+16K
15,610
0.49% of shares
low
Mar 16, 2026Chou William
CEO
GrantEmployee Stock Option (right to buy)+58K
58,000
1.80% of shares
low
Jan 8, 2026Borthwick Kathleen
Executive
ExerciseRestricted Stock Unit-5K
-50.00%
5,000
0.16% of shares
low
Jan 8, 2026Borthwick Kathleen
Executive
ExerciseCommon Stock+5K
+202.92%
7,464
0.23% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PASGCommon StockEquity702712209BBG00NBK4XF9